On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Adlego Biomedical AB's own share of each project, not the project's full budget.
- Horizon 2020€821k · 2 projects
- FP7 (2007 to 2013)€185k · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- Fight-nCoVPartner
FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€621ktheir share - OPENCORONAPartner
Rapid therapy development through Open nCoronavirus Vaccine Platform
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€200ktheir share - A-PARADDISEPartner
Anti-Parasitic Drug Discovery in Epigenetics
FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗
€185ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Aarhus UniversitetDenmark · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- Universita Degli Studi di Roma la SapienzaItaly · 1 shared project
- Institut PasteurFrance · 1 shared project
- Stockholms UniversitetSweden · 1 shared project
- Albert-Ludwigs-Universitaet FreiburgGermany · 1 shared project
- Universitaet UlmGermany · 1 shared project
- Universitaet Duisburg-EssenGermany · 1 shared project
- University of East AngliaUnited Kingdom · 1 shared project
- Justus-Liebig-Universitaet GiessenGermany · 1 shared project
- Centre Europeen de Recherche en Biologie et en MedecineFrance · 1 shared project
- Region StockholmSweden · 1 shared project
- Martin-Luther-Universitat Halle-WittenbergGermany · 1 shared project
- Inserm Transfert SAFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- coronaviruses
- drug discovery
- enzymes
- epigenetics
- immunotherapy
- malaria
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
